Table 1 Comparison of clinicopathological characteristics between non-conversion surgery group and conversion surgery group

Sex (M/F)

15/8

41/9

Age (years)

63.5(30–78)

66.5(25–75)

Performance Status 0/1

13/5

44/6

Tumor location (U/M/L/whole)

8/7/3/0

19/18/13/0

Macroscopic type (0/1/2/3/4/5)

0/1/6/11/0/0

0/2/24/24/0

Histological differentiation intestinal/diffuse

5/13

22/28

Distant metastatic site

 Hematogenous +/-

7/11

18/32

 Lymphogenous +/-

12/6

36/14

Multiple non-curative factors +/-

6/12

33/17

Yoshida’s Category 1/2

0/18

23/27

Albumin (g/dl) low/high

3.8

12/6

25/25

CEA (ng/ml) low/high

5

8/10

22/28

CA19-9 (U/ml) low/high

37

5/13

20/30

NLR low/high

3.1

3/15

28/22

PLR low/high

189

7/11

26/24

LMR low/high

3.7

13/5

20/30

CD4⁺ lymphocyte /Hpf low/high

15

9/9

21/29

CD8⁺ lymphocyte /Hpf low/high

34

16/2

38/12

Foxp3⁺lymphocyte /Hpf low/high

9

8/10

22/28

CD68⁺ macrophage /Hpf low/high

28

7/11

25/25

CD163⁺ macrophage /Hpf low/high

35

3/15

25/25